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Abstract
A tandem olefin metathesis/oxidative cyclization has been developed to synthesize 2,5-
disubstituted tetrahydrofuran (THF) diols in a stereocontrolled fashion from simple olefin 
precursors. The ruthenium metathesis catalyst is converted into an oxidation catalyst in the second 
step and is thus responsible for both catalytic steps. The stereochemistry of the 1,5-diene 
intermediate can be controlled through the choice of catalyst and the type of metathesis conducted. 
This olefin stereochemistry then controls the THF diol stereochemistry through a highly 
stereospecific oxidative cyclization.
Assisted tandem catalysis is an attractive synthetic strategy where a single catalyst is added 
at the outset of the reaction and is intentionally converted into a new species via a change in 
reaction conditions for a second catalytic step.1 Ruthenium alkylidene catalysts have been 
frequently used in assisted tandem catalysis in order to couple a metathesis step with other 
transformations, including but not limited to dihydroxylation, hydrogenation, and 
isomerization, showcasing the versatility of these complexes.2 We sought to further explore 
the dual nature of these alkylidene complexes in tandem catalysis.
The Ru- or Os-catalyzed oxidative cyclization of 1,5-dienes is a convenient method to 
prepare 2,5-disubstituted tetrahydrofuran (THF) diols in a stereocontrolled manner.6 
Furthermore, these THF diols are present in a wide variety of complex natural products 
(Figure 1). While olefin metathesis could be envisioned as a practical way to assemble the 
1,5-diene substrate, there have been no reports of utilizing alkylidene catalysts for oxidative 
cyclization. Herein we report the development of a tandem metathesis/oxidative cyclization 
capable of assembling a diverse set of THF diols, where the diol stereochemistry is 
determined from the intermediate olefin geometry set in the metathesis step.
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The oxidative cyclization of 1,5-dienes mediated by permanganate was discovered in 1965 
by Klein and Rojahn.7 Later, it was found that RuO48 or OsO49 can catalyze this 
transformation in the presence of a suitable oxidant, such as NaIO4 (Figure 2A). In 1979, 
Baldwin and Walba independently demonstrated the stereospecificity of the oxidative 
cyclization with respect to olefin geometry.10 The currently accepted mechanism involves 
initial [3 + 2]-cycloaddition with one of the olefins.6 Subsequently, the metallo ester 
intermediate undergoes a second [3 + 2]-cycloaddition with the pendant olefin, followed by 
hydrolysis, furnishing a THF diol. Each olefin dioxygenation step is stereospecific with 
respect to olefin geometry, analogous to olefin dihydroxylation. The cyclization step is also 
stereoselective with respect to the facial approach of the olefin and generally favors the 
cis-2,5-disubstituted THF.
Ruthenium alkylidene complexes have been shown to be converted into dihydroxylation 
catalysts upon treatment with NaIO4, and this has been used in the development of tandem 
metathesis/dihydroxylation.11 While the precise nature of the oxidized ruthenium species 
has not been firmly established, if this species is also capable of catalyzing oxidative 
cyclization, then 1,5-dienes accessible via olefin metathesis could be transformed into 2,5-
disubstituted THF diols in a stereocontrolled fashion (Figure 2B).
We envisioned that olefin metathesis could be a powerful approach to synthesizing the 
requisite 1,5-dienes necessary for oxidative cyclization with control of olefin geometry 
(Figure 2C). Cross metathesis is well studied and can achieve high E-selectivity through 
thermodynamic control for many substrate classes, including acrylates and bulky terminal 
olefins.12 Additionally, considerable effort in recent years has focused on metathesis 
catalysts capable of achieving high kinetic Z-selectivity.13 More recently, stereoretentive 
cross metathesis has also been developed.14
In order to test whether ruthenium alkylidene complexes are competent in oxidative 
cyclization, we chose to study the oxidation of bisacrylate 1. Using conditions optimized for 
ruthenium catalyzed dihydroxylation (NaIO4, catalytic CeCl3, 3:3:1 EtOAc/MeCN/H2O),15 
first generation, second generation, and cyclometalated alkylidene complexes Ru-1–5 
(Figure 3) all catalyzed the desired oxidative cyclization to give THF diol 2a (Table 1). 
While full conversion of 1 was observed in all cases, first generation complexes Ru-1,2 
produced significantly more byproducts, leading to lower yields of 2a. Second generation 
catalysts Ru-3,4 gave comparable yields (64% and 63%, entries 3 and 4). CeCl3 has been 
proposed to facilitate hydrolysis of ruthenate ester intermediates via acid catalysis as well as 
increase the redox potential.14c,16 In the absence of CeCl3, THF diol 2a was still obtained, 
albeit in lower yield (42%, entry 6). A control experiment in the absence of ruthenium led to 
complete recovery of bisacrylate 1, indicating that ruthenium is necessary for oxidation to 
occur (entry 7).
E,E-Bisacrylates such as 1 can be conveniently synthesized by ring-opening cross metathesis 
of 1,5-cyclooctadiene (3) with an α,β-unsaturated ester in the presence of a second 
generation catalyst such as Ru-3 or Ru-4.17 A tandem metathesis/oxidative cyclization was 
thus examined using 1,5-cyclooctadiene (3) as a 1,5-diene precursor. Ring-opening cross 
metathesis of 3 with a series of acrylates, followed by sequential treatment of the crude 
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solution with NaIO4 and catalytic CeCl3, produced the desired meso-THF diols 2 (Table 2). 
Both aryl and alkyl acrylates were effective. Upon scale-up to 2.5 mmol of 3, phenyl 
acrylate derived THF diol 2b was obtained in 52% yield (964 mg, entry 2). While the yields 
are moderate, we feel that the high degree of molecular complexity that can be achieved with 
a single catalyst renders the method highly attractive.18,19
We next wondered whether polybutadiene could be used in place of 1,5-cyclooctadiene (3) 
in the metathesis step, since the 1,5-olefin units in this polymer are expected to undergo 
cross metathesis to lead to the same E,E-bisacrylate intermediate as is formed with 3. The 
tandem sequence was performed using phenyl acrylate and polybutadiene (Mn = 3000, 
cis-1,4 content = 75%, trans-1,4 content = 24%, vinyl content = 1%), and THF diol 2b was 
obtained in 35% yield (Scheme 1). This result is valuable since polybutadiene is an 
inexpensive and widely available 1,5-diene building block. The molecular structure of 2b 
was determined by X-ray crystallography, as illustrated in Figure 4. The vicinal dioxygen 
stereocenters are threo, as expected for a syn dioxgenation of an E-olefin, and the THF ring 
substituents are oriented in a syn arrangement. This observed stereochemistry is consistent 
with previous reports on oxidative cyclization with RuO4.6
Next we examined cross metathesis/oxidative cyclization with unsymmetrical 1,5-dienes 
containing one hindered olefin (expected to be a spectator in the metathesis step) and one 
terminal olefin (capable of cross metathesis).12 E-5a underwent cross metathesis with benzyl 
acrylate followed by oxidative cyclization in sequential fashion to give THF diol 6a in 65% 
yield (Table 3, entry 1).20 Phenyl acrylate 4b and butyl acrylate 4c reacted in a similar 
fashion to produce 6b and 6c in 66% and 60% yields, respectively. Z-1,4-Diacetoxy-2-
butene 4d also underwent cross metathesis with 5a followed by oxidative cyclization to give 
monoacetate 6d in 59% yield.
If the geometry of the trisubstituted olefin is inverted, the resulting tertiary alcohol 
stereochemistry is also expected to invert. When Z-diene 5b was used with benzyl or phenyl 
acrylate, THF diols 6e and 6f were obtained in 69% and 73% yield, respectively. 
Hydrogenolysis of benzyl ester 6e yielded the monocarboxylic acid 7a, which provided 
crystals suitable for X-ray diffraction (Figure 5). The THF 2- and 5-substituents were found 
to be in a syn configuration, and the vicinal dioxygenation geometries are consistent with a 
syn-dioxygenation of the olefins. This is in agreement with expectations from previous 
reports on oxidative cyclization of 1,5-dienes with ruthenium catalysts6 (see Figure 2A).
E- and Z-ethyl substituted olefins 5c and 5d, as well as α,β-unsaturated-1,3-diester 5e, also 
underwent tandem cross metathesis/oxidative cyclization to provide THF diols 6g–i in 42–
73% yield (entries 7–9). Geminal dimethyl substitution on the diene linker was tolerated, as 
5f underwent reaction with 4a and 4b to give 6j and 6k in 76% and 63% yield, respectively. 
The allylic quaternary center presumably provided enough steric hindrance to prevent 
reversible metathesis of the ethyl acrylate moiety.
Having demonstrated that the hydroxyl stereochemistry of the THF diol depends on the 
olefin geometry of the 1,5-diene intermediate, we sought to use Z-selective metathesis in 
order to generate Z-diene intermediates in a catalytic fashion. Given the activity of 
Dornan et al. Page 3
J Am Chem Soc. Author manuscript; available in PMC 2017 May 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
cyclometalated alkylidene Ru-5 in the oxidative cyclization of 1 (Table 1), and the use of 
Ru-5 in tandem Z-selective cross metathesis–dihydroxylation,11d we anticipated that this 
complex would also be able to catalyze the oxidative cyclization of Z-diene intermediates in 
a stereospecific fashion. Using Ru-5 as catalyst, diene 5a and 5g underwent cross metathesis 
with an excess of allyl benzoate (5 equiv), to give an E,Z-diene intermediate, which then 
underwent oxidative cyclization upon exposure to the oxidative conditions to provide diol 6l 
and 6m in 45% and 30% yield,21 respectively (Scheme 2).
In conclusion, a tandem olefin metathesis/oxidative cyclization has been developed to 
generate 2,5-disubstituted THF diols in a stereocontrolled fashion. The stereochemistry of 
the intermediate 1,5-dienes can be controlled by the choice of catalyst in the metathesis step, 
and this stereochemistry is translated to the product in the oxidative cyclization. We are 
currently exploring mechanistic aspects of this process. It is envisioned that this 
methodology will provide a concise route to biologically important THF diol motifs as well 
as contribute to a greater understanding of tandem catalysis.
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Figure 1. 
Natural products3 containing the THF diol motif from the Annonaceous acetogenin4 and 
macrolide families.5
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Figure 2. 
(A) Oxidative cyclization of 1,5-dienes catalyzed by Ru or Os or mediated by Mn. (B) 
Proposed tandem metathesis/oxidative cyclization. (C) Types of olefin metathesis used in 
this study to generate the intermediate 1,5-dienes with control of olefin geometry.
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Figure 3. 
Ruthenium alkylidene catalysts examined in this study.
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Scheme 1. 
Cross Metathesis/Oxidative Cyclization Using Polybutadiene As a Source of 1,5-Diene
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Figure 4. 
Molecular structure of 2b determined by X-ray crystallography.
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Figure 5. 
Molecular structure of 7a determined by X-ray crystallography.
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Scheme 2. 
Z-Selective Cross Metathesis/Oxidative Cyclization
Dornan et al. Page 12
J Am Chem Soc. Author manuscript; available in PMC 2017 May 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Dornan et al. Page 13
Table 1
Comparison of Various Ru Alkylidene Catalysts in the Oxidative Cyclization of Bisacrylate 1
entry catalyst deviation from above 1 (%)a 2a (%)a
1 Ru-1 – 0 36
2 Ru-2 – 0 37
3 Ru-3 – 0 64
4 Ru-4 – 0 63
5 Ru-5 – 0 36
6 Ru-4 no CeCl3 0 42
7 none – 100 0
a
Determined by 1H NMR using mesitylene as an internal standard.
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Table 2
Tandem Ring-Opening Cross Metathesis/Oxidative Cyclization of 1,5-Cyclooctadiene with Terminal Olefins
Entry Terminal olefin Product Isolated Yield (%)a
1 50
2 57% (52%)b
3 41%c
a
Isolated as a single diastereomer.
bUsing 2.5 mmol of 3 (964 mg 2b isolated).
c
Isolated yield after benzoylation (for ease of purification).
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Table 3
Tandem Cross Metathesis/Oxidative Cyclization of 1,5-Dienes with Terminal Olefins
Entry 5 4 Product 6 Yield (%)a
l 5a 4a 6a 65
2 5a 4b 6b 66
3 5a 4c 6c 60
4 5a 4d 6d 59b
5 5b 4a 6e 69
6 5b 4b 6f 73
7 5c 4b 6g 73
8 5d 4b 6h 60
9 5e 4b 6i 42
10 5f 4a 6j 76
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Entry 5 4 Product 6 Yield (%)a
11 5f 4b 6k 63
a
Isolated as a single diastereomer.
b1.25 of equiv of 4d, 5 mol % Ru-4; see Supporting Information for details.
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